Revvity is a science-based solutions company operating at the intersection of life sciences and diagnostics. The firm supplies reagents, consumables, assays, and instruments to customers across pharma, biotech, diagnostic labs, academia, and government agencies. Its Signals software business is positioned to accelerate breakthrough solutions in these fields.
With a team of over 11,000 colleagues, Revvity serves customers in more than 190 countries from its headquarters in Waltham, Massachusetts. The company generates over $2.9 billion in annual revenue. Revvity was previously affiliated with PerkinElmer, Inc. and is part of the S&P 500 index.
Technical work at Revvity spans automation, multi-omics, and software, supporting its core mission of leveraging innovation across life sciences and diagnostics.
